What causes clitoromegaly is a question that points to excess androgen exposure in most cases, whether that exposure begins during fetal development or appears later in life. Clitoromegaly refers to a clitoral glans that exceeds age- and population-specific reference ranges, most often a stretched length above roughly 10 mm in adults. Causes range from congenital adrenal hyperplasia (CAH) and rare enzyme deficiencies to acquired triggers like androgen-secreting tumors, anabolic steroid use, or polycystic ovary syndrome (PCOS), and each driver changes the clinical response.
This walkthrough explains the hormonal, genetic, and medical factors behind an enlarged clitoris, then walks through how clinicians diagnose it and what shapes the treatment plan for adults and children.
Defining Clitoromegaly and Normal Clitoral Anatomy
Clitoral size varies across ethnic groups, body sizes, and stages of sexual development, so a single measurement means little without clinical context. A stretched clitoral length above roughly 10 mm in adults, or values above the 95th percentile for age in children, generally triggers evaluation. The distinction between congenital forms present at birth and acquired forms developing later shapes both the diagnostic pathway and the likely underlying mechanism.
Clitoromegaly is a clinical sign rather than a diagnosis in itself. Identifying the cause determines prognosis and guides your next steps, so the measurement always sits inside a broader exam that looks for other signs of androgen excess.
Reference Thresholds Worth Knowing
Most clinicians use the stretched clitoral length, measured from the pubic symphysis to the tip of the glans under gentle traction, as the standard. Adult values above 10 mm or pediatric values that cross the 95th percentile for age typically warrant workup. Width also matters: a clitoral index (length times width) above about 35 mm² raises concern in children.
Congenital Causes Rooted in Hormonal Development
Congenital adrenal hyperplasia (CAH), particularly 21-hydroxylase deficiency, is the leading cause in infants because excess adrenal androgens act on genital tissue during fetal development. The classic form produces virilization at birth that can range from mild clitoromegaly to more pronounced ambiguous genitalia. Other inborn enzyme deficiencies, including 11-hydroxylase and 3-hydroxysteroid dehydrogenase deficiencies, produce similar virilization through overlapping androgen pathways, and each one shifts the hormonal pattern in ways the lab work can usually distinguish.
Not every congenital case traces to the adrenal gland. In utero exposure to exogenous androgens or certain progestins remains a documented, though increasingly rare, cause of congenital clitoromegaly. Aromatase deficiency and placental aromatase mutations prevent conversion of androgens to estrogens, leaving the fetus exposed to elevated androgen levels and producing virilization that can be striking at birth.
Why Timing Matters in Utero
The genital tubercle responds to androgens primarily between roughly 7 and 12 weeks of gestation. Excess androgen exposure during this window drives clitoral growth that persists after birth, while later exposures generally cannot reshape fully formed anatomy. This timing window explains why some prenatal exposures cause lasting changes and others produce little visible effect.
Acquired Hormonal and Endocrine Triggers
Acquired clitoromegaly in adolescents and adults usually reflects new androgen exposure or a shift in the balance between androgen production and clearance. Anabolic-androgenic steroid use is a well-documented cause in female athletes and bodybuilders, with effects sometimes persisting for months after discontinuation. Polycystic ovary syndrome can produce mild enlargement through chronically elevated testosterone, though the change tends to be subtler than what tumor-related cases produce.
Androgen-secreting ovarian or adrenal tumors cause rapid-onset clitoromegaly in adults and represent a medical priority given their malignant potential. Exogenous testosterone and certain progestational medications, including some hormonal contraceptives used off-label, contribute to androgenic effects on clitoral tissue. The speed of onset often signals which category to investigate first.
Warning Signs That Point to a Tumor
Rapid virilization over weeks to a few months, especially with deepening voice, frontal balding, or rapid clitoral growth, calls for urgent endocrine and imaging workup rather than watchful waiting.
- Sudden onset: Noticeable changes developing over weeks instead of years
- Severe hirsutism: Coarse facial and body hair appearing quickly
- Voice change: Deepening or hoarseness without other explanation
- Menstrual disruption: Sudden amenorrhea in a previously regular cycle
- Clitoral growth speed: Visible change documented over a short interval
Non-Hormonal and Rare Structural Causes
Not every case traces to androgens. Neurofibromatosis type 1 may produce apparent enlargement through plexiform neurofibromas infiltrating the clitoral-inguinal region, which can mimic true glandular growth on casual exam. Other rare causes include clitoral cysts, epidermoid or dermoid tumors, and lymphatic malformations that sit near the clitoris and distort its appearance.
Chronic inflammatory or dermatologic conditions involving the vulva occasionally produce swelling mistaken for clitoromegaly on first glance. Idiopathic cases, where no hormonal or structural cause is identified after thorough workup, do exist and warrant careful follow-up rather than an assumption of normal anatomy. The category matters because the workup and counseling differ from androgen-driven cases.
When Anatomy Itself Mimics Disease
Some people present with what looks like clitoromegaly but turns out to be a prominent clitoral hood, a buried clitoris revealed after weight change, or post-surgical changes from prior genital surgery. A careful exam distinguishes these from true glandular enlargement, sparing the person unnecessary endocrine testing.
Diagnostic Pathways from Exam to Lab to Imaging
A focused physical exam establishes whether clitoral enlargement is genuine, records stretched length, and looks for associated signs of virilization such as hirsutism, voice deepening, or acne. The exam also screens for abdominal or pelvic masses that could signal an adrenal or ovarian tumor. From there, hormonal panels typically include total and free testosterone, DHEAS, 17-hydroxyprogesterone, androstenedione, and cortisol to distinguish adrenal from ovarian sources.
Pelvic ultrasound evaluates for ovarian masses or polycystic morphology, while adrenal imaging (CT or MRI) is indicated when an adrenal tumor is suspected or hormonal results suggest adrenal origin. Karyotyping may be considered in ambiguous or congenital cases to rule out intersex variations and inform counseling. The sequence of tests follows the most likely cause based on history and exam.
What Lab Patterns Reveal
| Hormone | Adrenal Source Suggestion | Ovarian Source Suggestion |
|---|---|---|
| 17-hydroxyprogesterone | Elevated in CAH (21-hydroxylase deficiency) | Usually normal |
| DHEAS | Elevated in adrenal tumors or CAH | Usually normal |
| Total testosterone | Mildly elevated in adrenal cases | Elevated in ovarian tumors or PCOS |
| Androstenedione | Elevated in adrenal disease | Elevated in ovarian tumors |
| Cortisol | Low in some CAH salt-wasting forms | Typically normal |
Reference intervals published by the Endocrine Society and WHO guide interpretation, though local lab ranges always take priority in clinical decision-making.
Treatment Approaches and What Determines the Right One
Treatment targets the underlying cause rather than the enlargement itself. Glucocorticoid replacement manages CAH by suppressing excess adrenal androgen production, tumor resection addresses neoplasms, and cessation of exogenous androgens reverses steroid-related cases in many instances. The goal is to stop the driver first, then reassess whether any anatomic change persists and warrants further attention.
Surgical reduction (clitoroplasty or clitoral reduction) is reserved for severe cases and is most commonly performed in childhood for congenital adrenal hyperplasia, with functional and sensory outcomes varying by technique. For PCOS-related mild enlargement, managing insulin resistance and androgen levels through lifestyle and pharmacologic therapy often reduces associated androgenic features over time. Long-term follow-up typically includes endocrinology, psychology, and, when relevant, genetics or ethics consultation to support informed decision-making across the lifespan.
Factors That Shape the Treatment Choice
- Underlying cause: CAH, tumor, PCOS, steroid exposure, or idiopathic
- Age at presentation: Congenital cases often addressed earlier than adult-onset
- Severity of enlargement: Mild cases may need only medical management
- Associated virilization: Broader symptom burden changes the urgency
- Fertility considerations: Relevant for adolescents and adults of reproductive age
- Patient priorities: Function, appearance, sensation, or symptom relief may weigh differently
When Surgery Becomes Part of the Plan
Clitoral reduction surgery carries real risks to sensation and future sexual function, so most guidelines reserve it for cases where medical management cannot address significant functional or anatomic concerns. A multidisciplinary team, including pediatric endocrinology, urology, psychology, and ethics, typically reviews any surgical decision in congenital cases.
Putting It Together
Clitoromegaly almost always points to excess androgen exposure, whether from a congenital enzyme deficiency, an acquired tumor, exogenous steroids, or PCOS. Identifying the specific driver through exam, hormonal panels, and targeted imaging shapes every decision that follows, from medication choice to whether surgery enters the conversation. Work with an endocrinologist or gynecologist experienced in this area, because the workup is straightforward when approached in the right order, and the right diagnosis is what protects both health and quality of life.
FAQ
What causes clitoromegaly in newborns?
The leading cause in newborns is congenital adrenal hyperplasia, especially the 21-hydroxylase deficiency form, which exposes the fetus to excess adrenal androgens during genital development. Less common causes include other enzyme deficiencies, aromatase deficiency, and rare in utero exposures to androgenic medications.
Is clitoromegaly a sign of congenital adrenal hyperplasia?
It often is, particularly when paired with other signs of virilization like fused labia or hyperpigmented genital skin. CAH accounts for the majority of congenital cases, though a hormonal panel measuring 17-hydroxyprogesterone and other steroids confirms the diagnosis rather than appearance alone.
Can PCOS cause an enlarged clitoris?
PCOS can produce mild enlargement through chronically elevated testosterone, though the change tends to be subtle compared with tumor-related cases. Managing insulin resistance and androgen levels often reduces associated androgenic features over time.
How is clitoromegaly diagnosed and evaluated?
Evaluation begins with a focused physical exam and stretched clitoral length measurement, followed by hormonal panels (testosterone, DHEAS, 17-hydroxyprogesterone, androstenedione, cortisol) and imaging of the ovaries and adrenals when indicated. Karyotyping may be added in congenital or ambiguous cases.
What are the treatment options for clitoromegaly?
Treatment targets the underlying cause: glucocorticoids for CAH, tumor removal for neoplasms, cessation of exogenous androgens for steroid-related cases, and metabolic management for PCOS. Surgical reduction is reserved for severe cases where medical management cannot resolve significant functional or anatomic concerns.
When does clitoromegaly require surgery?
Surgery is typically reserved for severe congenital cases, often performed in childhood for CAH-related virilization, and for select adult cases where medical treatment has not resolved significant functional issues. Multidisciplinary review usually precedes any surgical decision.
